Bunzl expands in Spain & Mexico with Quindesur & Gisa acquisitions, boosting cross-selling opportunities and strengthening regional presence. Read the analysis.
This article covers information on Bunzl PLC.
LON:BNZLBunzl has announced two new bolt-on acquisitions and confirmed completion of two previously announced deals. In Spain, it has acquired Quindesur, a distributor focused on foodservice and cleaning & hygiene in Southern Spain. In Mexico, it has completed the purchase of Guantes Internacionales, S.A. de C.V. (Gisa), a leading own brand distributor of personal protective equipment with a strong emphasis on gloves.
Two more deals – Solupack in Brazil and Hospitalia in Chile – have now completed following announcements earlier this year. The CEO describes Gisa and Quindesur as the fourth and fifth acquisitions of 2025, keeping Bunzl’s long-running buy-and-build strategy very much on the front foot.
| Company | Country | Focus | 2024 Revenue | Status |
|---|---|---|---|---|
| Quindesur | Spain | Foodservice; Cleaning & Hygiene | EUR 14 million (c.£12 million) | Completed (July 2025) |
| Gisa | Mexico | PPE – gloves; own brand | MXN 399 million (c.£17 million) | Completed (August 2025) |
| Solupack | Brazil | Own brand packaging for food industry | Not disclosed | Completed (July 2025) |
| Hospitalia | Chile | Healthcare distribution | Not disclosed | Completed (July 2025) |
These are classic Bunzl deals: targeted, category-focused and regionally complementary. Quindesur deepens coverage in Spain in two core categories where Bunzl already plays, which should help route density and service levels. Gisa plugs into PPE – a category where own brand can be a differentiator – and has immediate cross-selling potential into Bunzl’s existing customer base across North America and Mexico.
The completion of Solupack and Hospitalia extends the Latin American footprint across Brazil and Chile, adding packaging and healthcare exposure. Put together, this is Bunzl broadening both geography and product mix, while leaning into its compounding growth model through bolt-on M&A.
With disclosed 2024 revenues of around £12 million for Quindesur and around £17 million for Gisa, these look like bolt-on acquisitions rather than transformational changes. That is very much in character for Bunzl, which typically buys, integrates and optimises rather than swinging for the fences.
The strategic kicker here is twofold. First, Gisa’s glove-led PPE proposition in Mexico should travel well through Bunzl’s existing channels, especially given the US and Mexico footprint highlighted in the RNS. Second, Quindesur strengthens density in Southern Spain, which can improve delivery efficiencies and customer retention in foodservice and cleaning & hygiene.
This is Bunzl doing what it does best – layering in modest, targeted acquisitions that broaden reach and deepen category presence. The disclosed revenues suggest these are small deals in the context of the Group, but they carry clear strategic logic, particularly the PPE cross-selling potential from Gisa and the regional strengthening in Spain via Quindesur.
The absence of pricing, margins or EPS guidance is normal for Bunzl’s RNS style, so investors will need to wait for interim or full-year updates to see the early economic impact. For now, the message is continuity: a busy pipeline, disciplined deployment and yet more proof that the compounding acquisition engine is still running.
Net positive on strategy and portfolio quality, with the usual caveat that execution and FX will do some of the heavy lifting from here.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
185 viewsLikes
No ratings yet
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
No comments yet - start the conversation.